US PA Philadelphia Falk MJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
The Children's Hospital of Philadelphia | The Children's Hospital of Philadelphia | ||
Division of Human Genetics | Division of Human Genetics | ||
ARC - Room 1002c | ARC - Room 1002c | ||
3615 Civic Center Blvd | 3615 Civic Center Blvd | ||
Philadelphia, PA | Philadelphia, PA 19104, USA | ||
|city=Philadelphia | |city=Philadelphia | ||
|state=Pennsylvania (PA) | |state=Pennsylvania (PA) | ||
|country=USA | |country=USA | ||
|MiPNetLab=Falk MJ | |MiPNetLab=Falk MJ, Polyak E | ||
|keyword=Respiratory chain disease | |||
}} | }} | ||
* [[Talk:MiPNet_Reference_Laboratories#MiPNet Reference Laboratories - highlighted|MiPNet Reference Laboratory of the Week - 2012-05-06]] | * [[Talk:MiPNet_Reference_Laboratories#MiPNet Reference Laboratories - highlighted|MiPNet Reference Laboratory of the Week - 2012-05-06]] | ||
* ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]] | |||
Revision as of 12:01, 12 June 2012
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
